Cholangitis sclerosing – Basic Information

Go back

Primary sclerosing cholangitis is a rare and progressive liver disease that causes inflammation and scarring of the tubes that carry bile from the liver to the digestive system. Over time, these tubes narrow and become blocked, causing bile to back up into the liver and leading to serious damage. Many people have no symptoms when first diagnosed, yet the condition steadily worsens and can eventually lead to liver failure.

Epidemiology

Primary sclerosing cholangitis, often called PSC, is an uncommon condition that affects a small portion of the population. Researchers estimate that about 5 to 16 people out of every 100,000 have this disease, though some sources suggest approximately 1 in 10,000 people are affected.[3][19] Because PSC can exist without causing noticeable symptoms or abnormal blood tests in its early stages, many cases likely go undetected, meaning the true number of people living with the condition may be higher than current estimates suggest.[4]

The disease shows a clear pattern in terms of who is most commonly affected. PSC is more frequently diagnosed in men than in women, with men being affected about twice as often as women.[3][4] Most people receive their diagnosis between the ages of 30 and 40, although the disease can begin at any age, including childhood.[3][8] There is also a form called pediatric PSC that begins in children or teenagers, sometimes accompanied by another condition called autoimmune hepatitis.[1]

Geographic patterns reveal that PSC is more common in people of Northern European ancestry compared to those of Southern European or Asian descent.[4] Prevalence rates are similar across North America and Northern European countries, but lower estimates are reported in Asia and Southern Europe.[4][20] Over recent decades, there has been an increase in the number of diagnosed cases, though it remains unclear whether this represents a true rise in disease occurrence or improved detection methods.[20]

Causes

The exact cause of primary sclerosing cholangitis remains unknown, though medical experts believe it develops from a combination of factors working together. The most widely accepted theory is that PSC is an immune-mediated disease, meaning the body’s immune system mistakenly attacks its own healthy tissues.[1][2] In this case, the immune system targets the cells lining the bile ducts, causing chronic inflammation that eventually leads to scarring.

Genetics appear to play an important role in determining who might develop PSC. Having a family member with the condition increases your risk of developing it yourself.[8][21] Researchers have identified that certain genetic variations, particularly those in the human leukocyte antigen complex (a family of genes involved in immune function), may influence a person’s susceptibility to the disease.[9] However, having these genetic markers does not guarantee someone will develop PSC, suggesting that other factors must also be present.

Environmental factors are thought to act as triggers in people who are genetically predisposed to the condition. Exposure to certain bacteria, viruses, or toxins may somehow prompt the immune system to begin its inappropriate attack on bile duct cells.[2][8] Changes in the composition of bacteria living in the gut, known as the gut microbiome, may also contribute to disease development.[2][4]

⚠️ Important
Primary sclerosing cholangitis is not caused by alcohol consumption. Unlike some other liver diseases, PSC is not related to drinking beverages containing alcohol or any other lifestyle choices you might have made. It is an immune-mediated condition that occurs due to factors beyond your control.

Risk Factors

Several factors increase the likelihood of developing primary sclerosing cholangitis. The most significant risk factor is having inflammatory bowel disease, particularly a form called ulcerative colitis.[1][2] About 70 to 80 percent of people diagnosed with PSC also have inflammatory bowel disease, and conversely, about 3 to 7.5 percent of people with ulcerative colitis develop PSC.[3][4] This strong connection suggests shared mechanisms between the two conditions, though the exact relationship remains unclear.

Being male is another important risk factor. Men are approximately twice as likely as women to develop PSC.[3][4] Age also matters, with most diagnoses occurring between the ages of 30 and 60, particularly around age 40.[2][9] However, the condition can appear at any point in life, including during childhood and teenage years.

People who have other autoimmune diseases are also at increased risk. These include conditions such as celiac disease (an immune reaction to eating gluten), type 1 diabetes (where the immune system attacks insulin-producing cells in the pancreas), thyroid diseases, autoimmune hepatitis (where the immune system attacks the liver), and autoimmune pancreatitis (inflammation of the pancreas caused by immune dysfunction).[2][3] The presence of multiple autoimmune conditions in people with PSC suggests that immune system dysregulation is a core feature of the disease.

Interestingly, PSC is virtually always seen in nonsmokers, and there appears to be some protective effect from smoking, though this should never be interpreted as a reason to smoke given the many serious health risks associated with tobacco use.[4] Pre-existing liver disease may also increase susceptibility to developing PSC.[2]

Symptoms

The symptoms of primary sclerosing cholangitis vary considerably from person to person and change as the disease progresses. One of the most challenging aspects of PSC is that up to half of all people have no symptoms at the time of diagnosis.[2][4] In many cases, the disease is discovered accidentally during routine blood tests that show abnormal liver enzyme levels, particularly elevated alkaline phosphatase.[4]

When symptoms do appear, they often begin vaguely and may come and go over time. The earliest and most common symptom is extreme tiredness, called fatigue, which can be debilitating and affect daily activities.[2][4] Many people also experience severe itchy skin, known as pruritus, which can become intense enough to interfere with sleep and quality of life.[2][4] Pain in the upper right side of the abdomen, where the liver is located, is another common early symptom.[2]

As bile ducts become more narrowed and blocked, other symptoms emerge. Jaundice, which is a yellowing of the skin and the whites of the eyes, occurs when bile cannot flow properly and its components build up in the blood.[2][4] People may notice their urine becoming dark in color while their stool turns pale or clay-colored due to changes in bile excretion.[2] Fever and chills can signal an infection in the bile ducts, called bacterial cholangitis, which occurs when bile becomes trapped and bacteria multiply.[2][4] Unintended weight loss may occur as the disease interferes with the body’s ability to digest fats and absorb certain vitamins.[2]

As the disease advances and liver damage worsens, more serious symptoms appear. The abdomen may become swollen due to fluid accumulation, a condition called ascites.[2] Both the liver and spleen may become enlarged, which can sometimes be felt during a physical examination.[4] In severe cases, people may vomit blood or pass black, tar-like stools, which indicates bleeding from enlarged blood vessels in the digestive tract.[2]

Prevention

Unfortunately, because the exact cause of primary sclerosing cholangitis is not fully understood, there are no known methods to prevent the disease from developing. Unlike some other liver conditions that can be prevented through lifestyle modifications such as avoiding alcohol or maintaining a healthy weight, PSC appears to result from immune system dysfunction and genetic factors that cannot be controlled or modified.

However, once diagnosed with PSC, there are important steps people can take to help slow disease progression and manage complications. Regular monitoring through medical care is essential. Doctors typically recommend routine blood tests to track liver function and imaging studies to monitor the bile ducts.[3] Early detection of complications can lead to timely interventions that may improve outcomes.

Because PSC is strongly associated with inflammatory bowel disease, people diagnosed with PSC who do not yet have bowel symptoms may benefit from screening for inflammatory bowel disease. Similarly, those diagnosed with inflammatory bowel disease, particularly ulcerative colitis, may benefit from liver function monitoring to detect PSC early if it develops.

People with PSC should also undergo regular surveillance for certain cancers, as the disease increases risk for several malignancies. Regular colonoscopy examinations are recommended for those with both PSC and inflammatory bowel disease to screen for colorectal cancer.[3][11] Imaging tests and blood tests may be suggested to monitor for bile duct cancer, gallbladder cancer, and liver cancer.[3][11]

Lifestyle modifications, while not preventing PSC itself, may help support overall liver health and quality of life. Medical professionals recommend that people with PSC avoid alcohol completely, get adequate sleep, manage stress levels, and maintain healthy exercise habits.[19] Proper nutrition is particularly important because PSC can interfere with the absorption of fats and fat-soluble vitamins (vitamins A, D, E, and K).[9][11] Doctors may recommend vitamin supplements and a nutrient-rich diet to address these deficiencies.

Because PSC can lead to weakened bones, called osteoporosis, due to vitamin D deficiency and reduced calcium absorption, monitoring bone health and taking steps to strengthen bones may be beneficial.[9] This might include calcium and vitamin D supplementation as recommended by a healthcare provider.

Pathophysiology

Understanding what happens inside the body during primary sclerosing cholangitis helps explain why the disease causes such serious problems. The condition specifically targets the bile ducts, which are tube-like structures that carry bile from the liver to other parts of the digestive system.[1] Bile is a yellowish-green fluid produced by the liver that plays a crucial role in breaking down fats during digestion and helps the body absorb fat-soluble vitamins.

In PSC, the bile ducts both inside the liver (intrahepatic) and outside the liver (extrahepatic) become inflamed. This inflammation, called cholangitis, is chronic and persistent rather than temporary.[2][6] Over time, the ongoing inflammation causes the body to form scar tissue in and around the bile ducts, a process called sclerosis or fibrosis.[4]

As scar tissue builds up, the bile ducts gradually become narrower. These narrowed areas are called strictures, and they act like partial blockages in a drainage system.[2][4] When bile cannot flow freely through these narrowed ducts, it backs up and accumulates in the liver. This backup of bile, called cholestasis, exposes liver cells to toxic substances present in bile, causing direct damage to liver tissue.[2]

The disease progresses through distinct stages based on how much scarring has occurred. In stage 1, very little scarring exists, limited to specific areas of the liver called portal areas. By stage 2, the scarring has extended further but the scarred regions do not yet connect to each other. Stage 3 involves connecting areas of scarring throughout the liver. Finally, stage 4 represents widespread and connected scarring throughout the liver, resulting in cirrhosis, which is severe, permanent scarring that prevents the liver from functioning normally.[2][12]

As cirrhosis develops, the normal architecture of the liver becomes disrupted. Scar tissue blocks the normal flow of blood through the liver, causing high blood pressure in the blood vessels that drain into the liver, a condition called portal hypertension.[3] This increased pressure can lead to serious complications including fluid accumulation in the abdomen, enlarged blood vessels in the esophagus and stomach that can burst and bleed, and an enlarged spleen.

The narrowed bile ducts also create an environment where bacteria can more easily cause infections. Multiple episodes of life-threatening acute bacterial infections in the bile ducts can occur because the impaired drainage allows bacteria to multiply.[4] These infections cause fever, chills, and worsening jaundice, requiring immediate medical attention.

Over time, typically within 10 to 15 years after diagnosis, the accumulated liver damage can progress to liver failure, where the liver can no longer perform its essential functions of filtering blood, producing proteins, and supporting digestion.[2][12] Because the liver is essential for survival and the body cannot live without it, liver failure represents a life-threatening stage of the disease that may require liver transplantation.

⚠️ Important
People with PSC face an increased risk of developing several types of cancer, including cancer of the bile ducts (cholangiocarcinoma), gallbladder cancer, liver cancer, and colorectal cancer. Regular surveillance and monitoring are essential parts of managing PSC to detect these cancers as early as possible when treatment may be more effective.

Ongoing Clinical Trials on Cholangitis sclerosing

  • Study on Simvastatin for Treating Primary Sclerosing Cholangitis in Patients

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

References

https://www.mayoclinic.org/diseases-conditions/primary-sclerosing-cholangitis/symptoms-causes/syc-20355797

https://my.clevelandclinic.org/health/diseases/23569-primary-sclerosing-cholangitis

https://www.niddk.nih.gov/health-information/liver-disease/primary-sclerosing-cholangitis/definition-facts

https://en.wikipedia.org/wiki/Primary_sclerosing_cholangitis

https://cardiacsurgery.ucsf.edu/condition/primary-sclerosing-cholangitis

https://pscpartners.org/about/what-is-psc.html

https://liverfoundation.org/liver-diseases/autoimmune-liver-diseases/primary-sclerosing-cholangitis-psc/

https://www.cedars-sinai.org/health-library/diseases-and-conditions/p/primary-sclerosing-cholangitis-psc.html

https://medlineplus.gov/genetics/condition/primary-sclerosing-cholangitis/

https://www.mayoclinic.org/diseases-conditions/primary-sclerosing-cholangitis/diagnosis-treatment/drc-20355802

https://www.niddk.nih.gov/health-information/liver-disease/primary-sclerosing-cholangitis/treatment

https://my.clevelandclinic.org/health/diseases/23569-primary-sclerosing-cholangitis

https://liverfoundation.org/liver-diseases/autoimmune-liver-diseases/primary-sclerosing-cholangitis-psc/

https://pmc.ncbi.nlm.nih.gov/articles/PMC10662072/

https://www.uchicagomedicine.org/conditions-services/liver-diseases-hepatology/psc-and-autoimmune-liver-disease/primary-sclerosing-cholangitis-psc

https://liverfoundation.org/liver-diseases/autoimmune-liver-diseases/primary-sclerosing-cholangitis-psc/

https://my.clevelandclinic.org/health/diseases/23569-primary-sclerosing-cholangitis

https://pscsupport.org.uk/just-diagnosed-with-psc-10-things/

https://www.antidote.me/blog/living-with-psc

https://pmc.ncbi.nlm.nih.gov/articles/PMC4902039/

https://www.ummhealth.org/health-library/primary-sclerosing-cholangitis-psc

FAQ

Is there a cure for primary sclerosing cholangitis?

Currently, there is no medical treatment that can cure or reverse primary sclerosing cholangitis. A liver transplant is the only definitive treatment that can cure advanced disease, though the condition can recur in the transplanted liver. Treatment focuses on managing symptoms, preventing complications, and monitoring disease progression.

What is the life expectancy after being diagnosed with PSC?

After diagnosis, life expectancy typically ranges from 10 to 20 years on average, though this varies widely between individuals. Some people live much longer, particularly those who receive a liver transplant. The disease progresses at different rates in different people, and many factors influence outcomes including age at diagnosis, presence of symptoms, and development of complications.

Why is PSC so strongly linked to inflammatory bowel disease?

About 70 to 80 percent of people with PSC also have inflammatory bowel disease, most commonly ulcerative colitis. The reason for this strong connection is not fully understood, but researchers believe there may be shared immune system problems and genetic factors that predispose people to both conditions. However, many people with inflammatory bowel disease never develop PSC, and some people with PSC do not have inflammatory bowel disease.

Can diet or lifestyle changes help with PSC?

While diet and lifestyle changes cannot cure or slow PSC itself, they can help support overall health and manage some symptoms. Avoiding alcohol completely is recommended to prevent additional liver stress. A nutrient-rich diet helps address vitamin deficiencies common in PSC. Getting adequate sleep, managing stress, and maintaining healthy exercise habits may improve quality of life and overall well-being.

What tests are used to diagnose PSC?

PSC is often first suspected when routine blood tests show elevated liver enzymes, particularly alkaline phosphatase. The main diagnostic test is magnetic resonance cholangiopancreatography (MRCP), a type of MRI that creates detailed images of the bile ducts. Other tests that may be used include endoscopic retrograde cholangiopancreatography (ERCP), which involves inserting a tube through the mouth to view the bile ducts, and percutaneous transhepatic cholangiography, which uses a needle through the skin to inject dye into the bile ducts for X-ray imaging.

🎯 Key takeaways

  • Primary sclerosing cholangitis is a rare immune-mediated disease that causes progressive scarring and narrowing of bile ducts, affecting approximately 1 in 10,000 people.
  • Up to half of all people have no symptoms when first diagnosed, often discovering the condition through routine blood tests showing abnormal liver enzymes.
  • Men are twice as likely as women to develop PSC, with most diagnoses occurring between ages 30 and 40.
  • About 70 to 80 percent of people with PSC also have inflammatory bowel disease, particularly ulcerative colitis, though the connection between these conditions remains unclear.
  • The disease progresses over 10 to 15 years toward liver failure, and a liver transplant is currently the only curative treatment, though PSC can recur in 25 to 30 percent of transplanted livers.
  • PSC significantly increases the risk of several cancers including bile duct cancer, gallbladder cancer, liver cancer, and colorectal cancer, making regular surveillance essential.
  • No medical treatments can currently slow or reverse PSC, so care focuses on managing symptoms like severe itching, preventing complications such as bile duct infections, and monitoring disease progression.
  • PSC is not caused by alcohol consumption or any lifestyle factors, distinguishing it from many other liver diseases and eliminating the possibility of prevention through behavior modification.